NCT00744744 Health-Related Quality of Life in Patients With Bladder Cancer Status COMPLETED Phase N/A
NCT00729287 Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer Status COMPLETED Phase PHASE3
NCT00722553 Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder Status COMPLETED Phase PHASE2
NCT00714948 Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma Status TERMINATED Phase PHASE2
NCT00709462 A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) Status COMPLETED Phase PHASE1
NCT00696579 Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00694915 Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder Status COMPLETED Phase PHASE2
NCT00694798 Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder Status COMPLETED Phase PHASE1
NCT00666978 Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking Status COMPLETED Phase PHASE4
NCT00661609 A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer Status COMPLETED Phase PHASE2
NCT00648102 Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer Status COMPLETED Phase PHASE1
NCT00645593 Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer Status COMPLETED Phase PHASE2
NCT00635726 Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer Status TERMINATED Phase PHASE2
NCT00635336 Novel Peptide Vaccination for Patients With Advanced Bladder Cancer Status COMPLETED Phase PHASE1
NCT00634621 Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer Status COMPLETED Phase N/A
NCT00633204 Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer Status UNKNOWN Phase PHASE2
NCT00627432 Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer Status COMPLETED Phase PHASE2
NCT00623064 Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer Status COMPLETED Phase PHASE1
NCT00622973 USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases Status COMPLETED Phase PHASE3